Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Cipla
Revenue
=
Money Received
-
Discounts and Returns
=
70.21 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Based on latest financial disclosure Cipla Limited reported 70.21 B of revenue. This is 1393.02% higher than that of Healthcare sector, and 435.57% higher than that of Drug Manufacturers - Major industry, The Revenue for all stocks is 760.79% lower than the firm.
Filter other Stocks by Revenue
Specify Market Cap
Select Revenue Range
Current Range
Indicate Industry
Click to run this filter
Filter Other Equities
Cipla Limited is rated below average in revenue category among related companies. Market size based on revenue of Drug Manufacturers - Major industry is currently estimated at about 822.59 Billion. Cipla holds roughly 70.21 Billion in revenue claiming about 9% of equities under Drug Manufacturers - Major industry.
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
India Cipla Limited
-1.39% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
